Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16389 | 592 | 45.9 | 95% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2513 | 3376 | FOCAL ADHESION KINASE//INTEGRIN LINKED KINASE//FAK |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INTEGRIN LINKED KINASE | Author keyword | 154 | 67% | 24% | 141 |
2 | ILK | Author keyword | 77 | 62% | 13% | 79 |
3 | INTEGRIN LINKED KINASE ILK | Author keyword | 29 | 77% | 3% | 20 |
4 | PARVIN | Author keyword | 12 | 75% | 2% | 9 |
5 | PINCH1 | Author keyword | 9 | 83% | 1% | 5 |
6 | IPP COMPLEX | Author keyword | 8 | 100% | 1% | 5 |
7 | PINCH 1 | Author keyword | 8 | 100% | 1% | 5 |
8 | PINCH | Author keyword | 7 | 21% | 5% | 31 |
9 | KARL LANDSTEINER THORAC ONCOL | Address | 6 | 71% | 1% | 5 |
10 | AFFIXIN | Author keyword | 6 | 100% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTEGRIN LINKED KINASE | 154 | 67% | 24% | 141 | Search INTEGRIN+LINKED+KINASE | Search INTEGRIN+LINKED+KINASE |
2 | ILK | 77 | 62% | 13% | 79 | Search ILK | Search ILK |
3 | INTEGRIN LINKED KINASE ILK | 29 | 77% | 3% | 20 | Search INTEGRIN+LINKED+KINASE+ILK | Search INTEGRIN+LINKED+KINASE+ILK |
4 | PARVIN | 12 | 75% | 2% | 9 | Search PARVIN | Search PARVIN |
5 | PINCH1 | 9 | 83% | 1% | 5 | Search PINCH1 | Search PINCH1 |
6 | IPP COMPLEX | 8 | 100% | 1% | 5 | Search IPP+COMPLEX | Search IPP+COMPLEX |
7 | PINCH 1 | 8 | 100% | 1% | 5 | Search PINCH+1 | Search PINCH+1 |
8 | PINCH | 7 | 21% | 5% | 31 | Search PINCH | Search PINCH |
9 | AFFIXIN | 6 | 100% | 1% | 4 | Search AFFIXIN | Search AFFIXIN |
10 | QLT0267 | 6 | 100% | 1% | 4 | Search QLT0267 | Search QLT0267 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ILK | 211 | 76% | 25% | 147 |
2 | ONLY PROTEIN PINCH | 38 | 86% | 3% | 19 |
3 | EXPRESSION INCREASES | 36 | 83% | 3% | 20 |
4 | B AKT ACTIVATION | 34 | 93% | 2% | 13 |
5 | FOCAL ADHESION PROTEIN | 24 | 41% | 8% | 46 |
6 | INTEGRIN LINKED KINASE | 23 | 14% | 25% | 150 |
7 | CH ILKBP | 20 | 100% | 2% | 9 |
8 | GLYCOGEN SYNTHASE KINASE | 19 | 32% | 8% | 50 |
9 | REGULATES CELL ADHESION | 18 | 65% | 3% | 17 |
10 | INDUCED GENOTOXIC INJURY | 15 | 73% | 2% | 11 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase! | 2010 | 108 | 109 | 62% |
ILK, PINCH and parvin: the tIPP of integrin signalling | 2006 | 348 | 127 | 57% |
Integrin-linked kinase - essential roles in physiology and cancer biology | 2008 | 132 | 108 | 71% |
Integrin-linked kinase: A cancer therapeutic target unique among its ILK | 2005 | 321 | 125 | 60% |
Integrin-linked kinase: Not so 'pseudo' after all | 2011 | 50 | 80 | 60% |
Focal adhesion signaling and therapy resistance in cancer | 2015 | 3 | 188 | 15% |
Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes | 2001 | 237 | 34 | 88% |
Signalling via integrins: Implications for cell survival and anticancer strategies | 2007 | 196 | 218 | 33% |
The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer | 2007 | 162 | 74 | 32% |
PINCH, N(i)ck and the ILK: network wiring at cell-matrix adhesions | 2005 | 66 | 74 | 76% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | KARL LANDSTEINER THORAC ONCOL | 6 | 71% | 0.8% | 5 |
2 | JACK BELL | 5 | 16% | 4.4% | 26 |
3 | CELL ADHES SIGNALING | 4 | 75% | 0.5% | 3 |
4 | PAUL GERSON UNNA GRP SKIN HOMEOSTASIS AGEING | 2 | 44% | 0.7% | 4 |
5 | MOL MED CARDIOVASC DIS | 2 | 50% | 0.5% | 3 |
6 | BRITISH COLUMBIA CANC | 1 | 13% | 1.7% | 10 |
7 | GASTROENTEROL HEPATOL ENDOKRINOL CHARITE | 1 | 100% | 0.3% | 2 |
8 | JACK BELL CANC | 1 | 100% | 0.3% | 2 |
9 | CELL ADHES MATRIX | 1 | 11% | 1.4% | 8 |
10 | ANESTHESIA BIOCHEM | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000257394 | KINDLIN 2//KINDLIN//KINDLER SYNDROME |
2 | 0.0000100774 | FOCAL ADHESION KINASE//FAK//PYK2 |
3 | 0.0000071002 | CDKN3//CYCLIN DEPENDENT KINASE ASSOCIATED PROTEIN PHOSPHATASE//CYTOKINE EXPRESSION PATTERN |
4 | 0.0000069762 | FHL2//REDUCING BODY MYOPATHY//FHL1 |
5 | 0.0000068149 | ALPHA NAC//NASCENT POLYPEPTIDE ASSOCIATED COMPLEX//FIAT |
6 | 0.0000065819 | HUMAN MALIGNANT GLIOMAS//MOL EXPT RADIOL//RADGENOM GRP |
7 | 0.0000065031 | SCHLAFEN//SURG SERV 11S//SCHLAFEN 3 |
8 | 0.0000056528 | PDK1//AKT ISOFORMS//AKT2 |
9 | 0.0000050774 | FLIGHTLESS I//TTYH1//TWEETY |
10 | 0.0000049179 | PAK4//PAK1//P21 ACTIVATED KINASE |